{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:58:51Z","timestamp":1792792731363,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.rmed.2021.106522","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T05:04:38Z","timestamp":1624943078000},"page":"106522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China"],"prefix":"10.1016","volume":"186","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiansheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuntao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengdao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2021.106522_bib2","doi-asserted-by":"crossref","first-page":"1900588","DOI":"10.1183\/13993003.00588-2019","article-title":"Management of severe asthma: a European respiratory society\/American thoracic society guideline","volume":"55","author":"Holguin","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106522_bib3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1183\/09031936.03.00261903","article-title":"The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma","volume":"22","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106522_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/02770900601031540","article-title":"High prevalence of skin test positivity in severe or difficult-to-treat asthma","volume":"43","author":"Haselkorn","year":"2006","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmed.2021.106522_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2006.11.639","article-title":"Characterization of the severe asthma phenotype by the national heart, lung, and blood institute's severe asthma research Program","volume":"119","author":"Moore","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2021.106522_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106522_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(19)31147-X","article-title":"Prevalence, risk factors, and management of asthma in China: a national cross-sectional study","volume":"394","author":"Huang","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2021.106522_bib8","doi-asserted-by":"crossref","first-page":"B12","DOI":"10.1038\/35037009","article-title":"The role of allergy in the development of asthma","volume":"402","author":"Holt","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.rmed.2021.106522_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1067\/mai.2003.1595","article-title":"Allergic and nonallergic forms of atopic diseases","volume":"112","author":"Novak","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2021.106522_bib10","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jval.2018.07.788","article-title":"Factors of high asthma expenditure in China: an 1-year retrospective study","volume":"21","author":"Wang","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.rmed.2021.106522_bib11","first-page":"917","article-title":"[A cross-section study of severe asthma in eight provinces of China]","volume":"55","author":"Su","year":"2016","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.rmed.2021.106522_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2222.2005.02191.x","article-title":"Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy","volume":"35","author":"Holgate","year":"2005","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmed.2021.106522_bib13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm.164.supplement_1.2103024","article-title":"The role of immunoglobulin E in allergy and asthma","volume":"164","author":"Platts-Mills","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106522_bib14","series-title":"Novartis' Asthma Therapy Xolair Gets Approval in China. S & P Global Market Intelligence","year":"2017"},{"key":"10.1016\/j.rmed.2021.106522_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4168\/aair.2016.8.4.319","article-title":"Omalizumab improves quality of life and asthma control in Chinese patients with moderate to severe asthma: a randomized phase III study","volume":"8","author":"Li","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.rmed.2021.106522_bib16","first-page":"164","article-title":"[Emphasis on the special problems of asthma]","volume":"42","author":"Zhou","year":"2019","journal-title":"Zhonghua Jiehe He Huxi Zazhi"},{"key":"10.1016\/j.rmed.2021.106522_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/03007995.2019.1660539","article-title":"Cost-effectiveness of omalizumab for the treatment of moderate-to-severe uncontrolled allergic asthma in the United States","volume":"36","author":"Sullivan","year":"2020","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.rmed.2021.106522_bib18","article-title":"Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients","author":"Arrobas","year":"2020","journal-title":"Pulmonology"},{"key":"10.1016\/j.rmed.2021.106522_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1398-9995.2004.00533.x","article-title":"Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma","volume":"59","author":"Ayres","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2021.106522_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1753466619841350","article-title":"Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review","volume":"13","author":"Colombo","year":"2019","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.rmed.2021.106522_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/RMHP.S211321","article-title":"Omalizumab for severe allergic asthma treatment in Italy: a cost-effectiveness analysis from proxima study","volume":"13","author":"Canonica","year":"2020","journal-title":"Risk Manag. Healthc. Pol."},{"key":"10.1016\/j.rmed.2021.106522_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/1573398X13666170426094536","article-title":"Omalizumab in children with severe allergic asthma: the Italian real-life experience","volume":"13","author":"Licari","year":"2017","journal-title":"Curr. Respir. Med. Rev."},{"key":"10.1016\/j.rmed.2021.106522_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pupt.2018.11.002","article-title":"Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: results of a 5-YEAR single-centre observational study","volume":"54","author":"Pelaia","year":"2019","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2021.106522_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618810192","article-title":"Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness","volume":"12","author":"Pelaia","year":"2018","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.rmed.2021.106522_bib25","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jaci.2017.03.002","article-title":"Omalizumab in children with uncontrolled allergic asthma: review of clinical trial and real-world experience","volume":"139","author":"Chipps","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2021.106522_bib26","series-title":"China GDP Per Capita 1960-2020","year":"2020"},{"key":"10.1016\/j.rmed.2021.106522_bib27","series-title":"Pocket Guide for Asthma Management and Prevention","year":"2020"},{"key":"10.1016\/j.rmed.2021.106522_bib28","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1185\/03007995.2011.620950","article-title":"Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients","volume":"27","author":"Siergiejko","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.rmed.2021.106522_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/archdischild-2011-301570","article-title":"The oral corticosteroid-sparing effect of omalizumab in children with severe asthma","volume":"97","author":"Brodlie","year":"2012","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.rmed.2021.106522_bib30","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4168\/aair.2017.9.4.368","article-title":"Real-life efficacy of omalizumab after 9 Years of follow-up","volume":"9","author":"Menzella","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.rmed.2021.106522_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/1744666X.2019.1574571","article-title":"Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018","volume":"15","author":"MacDonald","year":"2019","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.rmed.2021.106522_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183869","article-title":"The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: the ASTERIX Observational study","volume":"12","author":"Bhutani","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.rmed.2021.106522_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2018.04.043","article-title":"Omalizumab effectiveness by biomarker status in patients with asthma: evidence from prospero, A prospective real-world study","volume":"7","author":"Casale","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.rmed.2021.106522_bib34","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2500\/aap.2012.33.3527","article-title":"Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data review","volume":"33","author":"Storms","year":"2012","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.rmed.2021.106522_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/1753466619841274","article-title":"Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study","volume":"13","author":"Solidoro","year":"2019","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.rmed.2021.106522_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011857","article-title":"Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)","volume":"6","author":"Niven","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.rmed.2021.106522_bib37","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.clinthera.2019.07.021","article-title":"Retrospective study on the association of biomarkers with real-world outcomes of omalizumab-treated patients with allergic asthma","volume":"41","author":"Kavati","year":"2019","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.rmed.2021.106522_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.rmed.2017.08.011","article-title":"Response to omalizumab in patients with severe allergic asthma: a real-life study","volume":"131","author":"Zierau","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2021.106522_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12325-019-01135-w","article-title":"The long-term effectiveness and safety of omalizumab on patient- and physician-reported asthma control: a three-year, real-life observational study","volume":"37","author":"Schreiber","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2021.106522_bib40","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/00325481.2017.1321945","article-title":"Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study","volume":"129","author":"Kallieri","year":"2017","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.rmed.2021.106522_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2019.07.026","article-title":"Long-term evaluation of response to omalizumab therapy in real life by a novel multimodular approach: the Real-life Effectiveness of Omalizumab Therapy (REALITY) study","volume":"123","author":"Singh","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.rmed.2021.106522_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/02770903.2018.1544642","article-title":"Cost-effectiveness of omalizumab for the treatment of inadequately controlled severe allergic asthma in Chinese children","volume":"57","author":"Zhou","year":"2020","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmed.2021.106522_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s41669-019-0117-4","article-title":"Economic impact and clinical outcomes of omalizumab add-on therapy for patients with severe persistent asthma: a real-world study","volume":"3","author":"Entrenas Costa","year":"2019","journal-title":"Pharmacoecon Open"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121002286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121002286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:22:21Z","timestamp":1760617341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611121002286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":42,"alternative-id":["S0954611121002286"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106522","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106522"}}